Drugmaker tried to shred records before FDA inspection, agency claims

(By Alia Paavola for Becker’s Hospital Review)

FDA inspectors claim that Strides Pharma Science, an India-based drugmaker that sells numerous drugs in the U.S., attempted to shred and dispose of quality-control records prior to an agency inspection, according to Bloomberg.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

 

Leave a Reply